Fundamentals of EU Regulatory Affairs Fifth Edition Fundamentals of EU Regulatory Affairs Fifth Edition Copyright © 2011 by the Regulatory Affairs Professionals Society.…

28 June 2011 EMA/306870/2011 Office of the Executive Director Annual report 2010 Adopted by the Management Board in June 2011 7 Westferry Circus ● Canary Wharf ● London…

1. European Union actionin the field of Rare Diseases Gastein, 1st October 2009 Antoni Montserrat Moliner European CommissionDG SANCO Health Information Unit 2. Legal basis…

1. IRDiRC: State of the Art Paul Lasko, PhD Canadian Institutes of Health Research Chair, IRDiRC Executive Committee 1 2. Rare disease research in 2010  Large-scale global…

1. Drug legislation with data fusion rules using multiple fingerprints measurements The 5th International Conference on Innovations in Bio-Inspired Computing and Applications.…

Slide 1 I M I The Innovative Medicines Initiative Member/Associated States Contact Group 20 March 2006 Octavi Quintana-Trias, EC Slide 2 The Political Situation JTI’s Some…

Slide 1 Treatment of children with rare metabolic diseases in Poland benefits of centralized system Jolanta Sykut-Cegielska, MD, PhD, Ass Prof Department of Metabolic Diseases,…

Orphan Designation split into Three Separate Areas for consideration Orphan Medicinal Designation: conducted by the Committee for Orphan Medicinal Products (COMP): Granting…

Rare Disease Activities in Europe 2018 Version Authors: Hedley, Victoria; Murray, Hannah; Rodwell, Charlotte*; Aymé, Ségolène* *In certain sections,